TARSONS
Plastic Products
₹548.85
0.00 (0.00%)
Market Cap | 2,963 Cr | EPS | 15.2 | High | 559.5 | ||
Stock P/E | 36.7 | Net Profit Margin | 27.8 | Low | 545.85 |
Performance
Today’s Low
Today’s High
545.85
559.5
52W Low
52W High
501.1
914.45
Open Price | 559.5 | Volume | 220 |
Prev. Close | 556.7 |
Fundamentals
Market Cap | 2,963 Cr | ROE | 27.4% | ||
P/E Ratio(TTM) | 36.7 | EPS(TTM) | 0.0 | ||
P/B Ratio | 5.2 | Dividend Yield | 0.0% | ||
Industry P/E | 92.6 | Book Value | 107.0 | ||
Face Value | 2.0 |
About the Company
Tarsons Products is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (CROs), Diagnostic companies and hospitals. It manufactures a range of quality labware products which helps advance scientific discovery and improve healthcare. The company’s product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors and others.
The company caters to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, diagnostic companies, and hospitals. Some of its end customers include customers such as Indian Institute of Chemical Technology, National Centre for Biological Sciences across academic institutes and research organizations; Dr Reddy's Laboratories, Enzene Biosciences across pharmaceutical sectors; Syngene International, Veeda Clinical Research across CROs; and Molbio Diagnostics, Agappe Diagnostic, Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors such as diagnostics. It distributes its products to these end customers on a pan-India basis through its authorised distributors. It has long-standing relationships with its end customers as well as distributors, which it has achieved by aligning its offerings with their business needs and through the support of an on-ground sales and marketing team.
Business area of the company
The company presently manufactures disposable plastic labware, centrifuge ware, cryo labware, liquid handling system and instruments.
Major events and milestones
- 1983: Incorporation of the Company with manufacturing of reusable plastic products.
- 1984: Commenced production of pipette tips.
- 1987: Commenced production of CFT.
- 2002: Pioneered the first fully robotic clean room plant for manufacturing of molecular biology consumables.
- 2009: Obtained ISO 9001:2015 certificate for manufacturing facility.
- 2012: Set up manufacturing facility expanding into production of fully automatic centrifuge tubes, and cryogenic vials in Dhulagarh.
- 2018: Obtained ISO 13485:2016/NS-EN ISO 13485:2016 certificate for manufacturing facility.
- 2018: Clear Vision Investment Holdings acquired 49% equity shareholding in the Company.
- 2019: Set up line for PCR products in Jalan Industrial Complex at Jangalpur.
- 2020: Received CE-IVD certification for products.
- 2019-2021: Acquired 5 acres land to develop a facility for increase in production in Panchla.
Parent Organization | Tarsons Products Ltd. | Managing Director | Sanjive Sehgal | ||
Founded | 1983 | NSE Symbol | TARSONS |
Financials
All values are in Rs Cr
Shareholding Pattern
Promoters
47.31%
Mutual Funds
7.66%
Foreign Institutions
9.12%
Domestic Institutions
7.76%
Promoters
47.31%
Mutual Funds
7.66%
Foreign Institutions
9.12%
Domestic Institutions
7.76%
Promoters
47.31%
Mutual Funds
7.66%
Foreign Institutions
9.12%
Domestic Institutions
7.76%
Promoters
47.31%
Mutual Funds
7.66%
Foreign Institutions
9.12%
Domestic Institutions
7.76%
Promoters
47.31%
Mutual Funds
7.66%
Foreign Institutions
9.12%
Domestic Institutions
7.76%
Peer Comparison
Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
---|---|---|---|---|---|
548.85(-1.4%) | 36.7 | ||||
172.1(-1.1%) | 886.6 | ||||
691.4(-2.5%) | 1.8 | ||||
696.55(-1.9%) | 116.9 |